Stimcell Energetics, Inc. Stimcell Energetics, Inc.

Stimcell Energetics, Inc.

STME

Rank in Stocks #29867
StimCell Energetics Inc. is a biotechnology company focused on the research,... StimCell Energetics Inc. is a biotechnology company focused on the research, development, and market introduction of both therapeutic and non-therapeutic solutions. These products are intended to benefit individuals in the United States who are managing conditions such as diabetes, Parkinson's disease, hypertension, neuropathy, and issues with kidney function. The company's primary product line is the eBalance system, which comprises two versions: the eBalance Pro System, designed for clinical application by healthcare practitioners, and the eBalance Home System, created for personal use to promote overall well-being and alleviate pain. Both systems are operated via the eBalance Console, a central control unit that offers three distinct pre-programmed microcurrent algorithms: one for general wellness, another for pain relief, and a 'dual' mode that combines both. Additionally, these eBalance products aim to provide temporary relief for discomfort in various body parts, including the shoulders, waist, back, neck, arms, and legs. Established in 2010, the company initially operated under the name Cell MedX Corp. before officially rebranding as StimCell Energetics Inc. in November 2024. Its corporate headquarters are located in Vancouver, Canada.
Share Price
$0.3
Last synced: 2026-11-13
Market Cap
$6.34M
Change (1 day)
29.25%
Change (1 year)
-37.50%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade Stimcell Energetics, Inc. (STME)

Category

Healthcare
Operating Margin for Stimcell Energetics, Inc. (STME)
Operating Margin as of November 2026 TTM: 0.00%
According to Stimcell Energetics, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Stimcell Energetics, Inc. from 2011 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 0.00% 0.00%
2025 0.00% 0.00%
2024 0.00% -100.00%
2023 -16,207.75% 46.35%
2022 -11,074.91% 0.00%
2021 -11,074.91% 922.05%
2020 -1,083.60% 0.00%
2019 -1,083.60% 0.00%
2018 0.00% -100.00%
2017 -25,020.76% 648.46%
2016 -3,342.96% -41.92%
2015 -5,756.09% 13,141.52%
2014 -43.47% 0.00%
2013 0.00% 0.00%
2012 0.00% 0.00%
2011 0.00% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
15.00% -
US
18.08% -
IE
21.25% -
US
21.05% -
US
25.52% -
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Stimcell Energetics, Inc.'s operating margin

What was Stimcell Energetics, Inc.'s operating margin in 2025?

In 2025, Stimcell Energetics, Inc.'s operating margin was 0.00%, compared with 0.00% in 2024.

How has Stimcell Energetics, Inc.'s operating margin changed since 2020?

From 2020 to 2025, Stimcell Energetics, Inc.'s operating margin was highest in 2025 (0.00%) and lowest in 2023 (-16,207.75%).

How does Stimcell Energetics, Inc.'s operating margin compare with similar companies?

Stimcell Energetics, Inc.'s operating margin (0.00%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 25.52%.